The Business of Cannabis Awards Return to London for a Third Year

Press releases
Read More

Cannabis Europa Launches Reimagined VIP Experience: A New Standard for Senior Decision Makers

Press releases
Read More

Ananda Pharma Cleared to Begin Dosing in NHS-Backed CBD Endometriosis Trial

Clinical Research
Read More

Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls

Data & Analysis
Read More

Recent Searches

    Popular Searches

    • Glass Pharms
    • medical
    • Medical Cannabis
    • Kanabo Calls in Administrators
    • Article
    • Cannabis Health Symposium
    • antiflamx near me abbotsford bc
    • teaching feeling scene
    • for driving licence test
    • LEADER AM

    Recent Searches

      Popular Searches

      • Glass Pharms
      • medical
      • Medical Cannabis
      • Kanabo Calls in Administrators
      • Article
      • Cannabis Health Symposium
      • antiflamx near me abbotsford bc
      • teaching feeling scene
      • for driving licence test
      • LEADER AM
      Medical, Videos, Your #1 Podcast on Cannabis News

      Stephen Murphy, Co-Founder + CEO, NOBL Group

      By
      BofC

      Stephen Murphy is the co-founder + CEO of NOBL – the company behind European Cannabis Week, Cannabis Europa and Prohibition Partners. Together, these brands are driving cannabis knowledge and insight into the European cannabis market. As well, Cannabis Europa is bringing their programming to Toronto on November 5th and New York City on November 7th.

      ‍

      BofC

      Other featured articles

      Ananda Pharma Cleared to Begin Dosing in NHS-Backed CBD Endometriosis Trial

      By

      Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls

      By

      The Scramble for Europe

      By

      ‘You Can’t Treat What You Can’t Measure’ – The Plan to Make the Endocannabinoid System Impossible to Ignore

      By

      Evidena Care Launches Switzerland’s First Integrated Medical Cannabis Market Comparison Platform

      By

      Other featured Medical articles

      Clinical Evidence vs. Food Law: Europe’s CBD Dilemma

      By

      France’s Medical Cannabis Framework: Built for Patients or for Regulators?

      By

      New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban recovery, With a Catch

      By

      Cannabis Europa Paris 2026: France’s Medical Cannabis Reimbursement Plans Revealed

      By

      Access, Saturation, Consolidation: Why Denmark Foreshadows the Future of Europe’s Medical Cannabis Markets

      By

      Share Article

      Related news

      Clinical Research
      Ananda Pharma Cleared to Begin Dosing in NHS-Backed CBD Endometriosis Trial

      By

      Data & Analysis
      Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls

      By

      Industry Trends
      The Scramble for Europe

      By

      Data & Analysis
      ‘You Can’t Treat What You Can’t Measure’ – The Plan to Make the Endocannabinoid System Impossible to Ignore

      By

      Press releases
      Evidena Care Launches Switzerland’s First Integrated Medical Cannabis Market Comparison Platform

      By

      CBD Market
      Clinical Evidence vs. Food Law: Europe’s CBD Dilemma

      By

      Policy & Regulation
      France’s Medical Cannabis Framework: Built for Patients or for Regulators?

      By

      Data & Analysis
      New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban recovery, With a Catch

      By

      Events
      Cannabis Europa Paris 2026: France’s Medical Cannabis Reimbursement Plans Revealed

      By